PMID:19649921: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
New PMID: Page!
 
Fill PMID: Page!
 
Line 1: Line 1:
PMID on Demand placeholder
{{RightTOC}}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.183632.U53afe4e9bbd35-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="U53afe4e9bbd35"  class=" tableEdit PMID_info_table" 
 
|-
!align=left  |Citation
||
'''Górski, A, Miedzybrodzki, R, Borysowski, J, Weber-Dabrowska, B, Lobocka, M, Fortuna, W, Letkiewicz, S, Zimecki, M and Filby, G'''  (2009) Bacteriophage therapy for the treatment of infections. ''Curr Opin Investig Drugs'' '''10''':766-74
|-
!align=left  |Abstract
||
Increasing levels of antibiotic resistance constitutes one of the main challenges in medicine today, and has increased interest in the potential use of alternative antibacterial agents. One of the most interesting 'classes' of novel antibacterials used to combat multidrug-resistant bacteria is bacteriophages, which are viruses that specifically infect and kill bacterial cells. This review discusses the current status of bacteriophage therapy, including the experience of one expert center specializing in this form of treatment.
|-
!align=left  |Links
||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19649921 PubMed]
 
|-
!align=left  |Keywords
||
Bacterial Infections/prevention & control; Bacterial Infections/therapy; Bacteriophages; Drug Resistance, Multiple, Bacterial; Humans
 
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.183632.U53afe4e9bbd35&page=183632&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> ||
|}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.183632.U53afe4e9bbd35-->
 
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
 
== Useful Materials and Methods {{HelpIcon|Help:Literature}}==
{{LitMaterials}}
 
==Annotations {{HelpIcon|Help:Literature}}==
<annotationlinks/>
 
==EcoliWiki Links {{HelpIcon|Help:Literature}} ==
{{LitLinks}}
 
==See also==
 
==References==
{{RefHelp}}
<references/>

Latest revision as of 10:05, 29 June 2014

Citation

Górski, A, Miedzybrodzki, R, Borysowski, J, Weber-Dabrowska, B, Lobocka, M, Fortuna, W, Letkiewicz, S, Zimecki, M and Filby, G (2009) Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs 10:766-74

Abstract

Increasing levels of antibiotic resistance constitutes one of the main challenges in medicine today, and has increased interest in the potential use of alternative antibacterial agents. One of the most interesting 'classes' of novel antibacterials used to combat multidrug-resistant bacteria is bacteriophages, which are viruses that specifically infect and kill bacterial cells. This review discusses the current status of bacteriophage therapy, including the experience of one expert center specializing in this form of treatment.

Links

PubMed

Keywords

Bacterial Infections/prevention & control; Bacterial Infections/therapy; Bacteriophages; Drug Resistance, Multiple, Bacterial; Humans

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

<annotationlinks/>

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

See also

References

See Help:References for how to manage references in EcoliWiki.